Mark D. Stegall

26.8k total citations · 3 hit papers
323 papers, 17.5k citations indexed

About

Mark D. Stegall is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark D. Stegall has authored 323 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Transplantation, 157 papers in Surgery and 83 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark D. Stegall's work include Renal Transplantation Outcomes and Treatments (211 papers), Organ Transplantation Techniques and Outcomes (113 papers) and Organ Donation and Transplantation (67 papers). Mark D. Stegall is often cited by papers focused on Renal Transplantation Outcomes and Treatments (211 papers), Organ Transplantation Techniques and Outcomes (113 papers) and Organ Donation and Transplantation (67 papers). Mark D. Stegall collaborates with scholars based in United States, United Kingdom and Netherlands. Mark D. Stegall's co-authors include J.M. Gloor, Walter K. Kremers, Timothy S. Larson, Borja G. Cosío, Patrick G. Dean, Matthew D. Griffin, Fernando G. Cosio, Lynn D. Cornell, James M. Gloor and Walter D. Park and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mark D. Stegall

314 papers receiving 17.1k citations

Hit Papers

RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLA... 1993 2026 2004 2015 1993 2009 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSIS
    1993 854 citations Stuart J. Knechtle, Mark D. Stegall et al. Transplantation profile →
  2. Identifying Specific Causes of Kidney Allograft Loss
    2009 614 citations Mark D. Stegall, Walter K. Kremers et al. American Journal of Transplantation profile →
  3. Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
    2011 425 citations Mark D. Stegall, Tayyab S. Diwan et al. American Journal of Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Stegall United States 73 11.0k 8.5k 3.9k 3.7k 2.6k 323 17.5k
Christophe Legendre France 76 9.1k 0.8× 5.1k 0.6× 4.3k 1.1× 2.3k 0.6× 1.8k 0.7× 426 18.5k
Flavio Vincenti United States 66 9.6k 0.9× 5.3k 0.6× 2.5k 0.6× 2.1k 0.6× 1.4k 0.5× 270 16.4k
Edgar L. Milford United States 47 5.5k 0.5× 4.2k 0.5× 2.7k 0.7× 3.2k 0.9× 1.6k 0.6× 164 13.3k
Josep M. Grinyó Spain 57 7.3k 0.7× 4.1k 0.5× 1.7k 0.4× 1.6k 0.4× 970 0.4× 285 11.7k
E. Steve Woodle United States 58 5.2k 0.5× 5.0k 0.6× 790 0.2× 2.1k 0.6× 1.2k 0.5× 354 11.6k
David N. Rush Canada 47 6.4k 0.6× 4.1k 0.5× 2.1k 0.5× 1.4k 0.4× 1.1k 0.4× 145 8.8k
Johan W. de Fijter Netherlands 57 5.2k 0.5× 3.4k 0.4× 1.9k 0.5× 1.3k 0.4× 1.0k 0.4× 323 11.1k
Denis Glotz France 50 6.0k 0.5× 3.8k 0.4× 2.2k 0.6× 1.2k 0.3× 902 0.3× 206 9.0k
Björn Nashan Germany 55 5.9k 0.5× 5.3k 0.6× 602 0.2× 1.4k 0.4× 1.1k 0.4× 377 12.8k
Rainer Oberbauer Austria 50 4.0k 0.4× 3.2k 0.4× 2.8k 0.7× 1.5k 0.4× 1.4k 0.5× 297 10.3k

Countries citing papers authored by Mark D. Stegall

Since Specialization
Citations

This map shows the geographic impact of Mark D. Stegall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Stegall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Stegall more than expected).

Fields of papers citing papers by Mark D. Stegall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Stegall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Stegall. The network helps show where Mark D. Stegall may publish in the future.

Co-authorship network of co-authors of Mark D. Stegall

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Stegall. A scholar is included among the top collaborators of Mark D. Stegall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Stegall. Mark D. Stegall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Amanda, Alexandre Loupy, Eric C. Frey, et al.. (2024). Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival. American Journal of Transplantation. 24(10). 1784–1793. 5 indexed citations
2.
Kukla, Aleksandra, P Navrátil, Roberto P. Benzo, et al.. (2024). Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity. Mayo Clinic Proceedings. 99(5). 705–715. 8 indexed citations
3.
Lorenz, Elizabeth C., Byron H. Smith, Walter D. Park, et al.. (2024). Increased Pretransplant Inflammatory Biomarkers Predict Death With Function After Kidney Transplantation. Transplantation. 108(12). 2434–2445. 4 indexed citations
4.
Alexander, Mariam P., Mark Zaidi, Nicholas B. Larson, et al.. (2023). Exploring the single-cell immune landscape of kidney allograft inflammation using imaging mass cytometry. American Journal of Transplantation. 24(4). 549–563. 8 indexed citations
5.
Vincenti, Flavio, Oriol Bestard, Josep M. Cruzado, et al.. (2023). Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant. Journal of the American Society of Nephrology. 35(3). 347–360. 14 indexed citations
6.
Klein, Amanda, Alexandre Loupy, Mark D. Stegall, et al.. (2023). Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes. American Journal of Transplantation. 23(10). 1496–1506. 14 indexed citations
7.
Heilman, Raymond L., James N. Fleming, Byron H. Smith, et al.. (2023). Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation. Clinical Transplantation. 37(8). e14987–e14987. 2 indexed citations
8.
D’Costa, Matthew R., Massini Merzkani, Aleksandar Đenić, et al.. (2022). Clinical and kidney structural characteristics of living kidney donors with nephrolithiasis and their long-term outcomes. Digital Commons@Becker (Washington University School of Medicine). 1 indexed citations
9.
Loon, Elisabet Van, Joseph Pierre Aboumsallem, Evelyne Lerut, et al.. (2020). Mesangial matrix expansion in a novel mouse model of diabetic kidney disease associated with the metabolic syndrome. Journal of Nephropathology. 10(2). e17–e17. 1 indexed citations
10.
Bentall, Andrew, Byron H. Smith, Walter D. Park, et al.. (2019). Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials. American Journal of Transplantation. 19(8). 2274–2283. 3 indexed citations
11.
Kashyap, Rahul, Ryan D. Frank, Vivek Iyer, et al.. (2019). Preoperative Factors Predicting Admission to the Intensive Care Unit After Kidney Transplantation. SHILAP Revista de lepidopterología. 3(3). 285–293. 8 indexed citations
12.
Loupy, Alexandre, Olivier Aubert, Babak J. Orandi, et al.. (2017). A MULTIDIMENSIONAL PROGNOSTIC SCORE AND NOMOGRAM TO PREDICT KIDNEY TRANSPLANT SURVIVAL: THE INTEGRATIVE BOX (IBOX) SYSTEM. Transplant International. 30. 55–56. 3 indexed citations
13.
Stegall, Mark D., Peter G. Stock, Kenneth A. Andreoni, John J. Friedewald, & Alan B. Leichtman. (2016). Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation system. Human Immunology. 78(1). 4–8. 40 indexed citations
14.
Bentall, Andrew, Loren Herrera, Lynn D. Cornell, et al.. (2014). Differences in Chronic Intragraft Inflammation Between Positive Crossmatch and ABO-Incompatible Kidney Transplantation. Transplantation. 98(10). 1089–1096. 21 indexed citations
15.
Cornell, Lynn D., J.M. Gloor, Manish J. Gandhi, et al.. (2009). Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrology Dialysis Transplantation. 25(1). 307–310. 47 indexed citations
16.
Park, Walter D., Matthew D. Griffin, Joseph P. Grande, Fernando G. Cosio, & Mark D. Stegall. (2007). Molecular Evidence of Injury and Inflammation in Normal and Fibrotic Renal Allografts One Year Posttransplant. Transplantation. 83(11). 1466–1476. 31 indexed citations
17.
Rea, David, Julie K. Heimbach, Joseph P. Grande, et al.. (2006). Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney International. 70(9). 1636–1641. 103 indexed citations
18.
Johnson, Christopher P., Nasimul Ahsan, Thomas A. Gonwa, et al.. (2000). RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2. Transplantation. 69(5). 834–841. 229 indexed citations
19.
Stegall, Mark D., Greg Everson, G Schröter, et al.. (1997). Prednisone Withdrawal Late After Adult Liver Transplantation Reduces Diabetes, Hypertension, and Hypercholesterolemia Without Causing Graft Loss. Hepatology. 25(1). 173–177. 109 indexed citations
20.
Am, D'Alessandro, Stephen J. Gange, Stuart J. Knechtle, et al.. (1994). Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation.. PubMed. 26(2). 531–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Legendre Breakdown of academic impact, for papers by Flavio Vincenti Breakdown of academic impact, for papers by Edgar L. Milford Breakdown of academic impact, for papers by Josep M. Grinyó Breakdown of academic impact, for papers by E. Steve Woodle Breakdown of academic impact, for papers by David N. Rush Breakdown of academic impact, for papers by Johan W. de Fijter Breakdown of academic impact, for papers by Denis Glotz Breakdown of academic impact, for papers by Björn Nashan Breakdown of academic impact, for papers by Rainer Oberbauer
Rankless by CCL
2026